<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39392000</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>41</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill</ISOAbbreviation></Journal><ArticleTitle>Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2400021</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2024.29.41.2400021</ELocationID><Abstract><AbstractText>BackgroundDespite the unprecedented measures implemented globally in early 2020 to prevent the spread of SARS-CoV-2, Sweden, as many other countries, experienced a severe first wave during the COVID-19 pandemic.AimWe investigated the introduction and spread of SARS-CoV-2 into Sweden.MethodsWe analysed stored respiratory specimens (n = 1,979), sampled 7 February-2 April 2020, by PCR for SARS-CoV-2 and sequenced PCR-positive specimens. Sequences generated from newly detected cases and stored positive specimens February-June 2020 (n = 954) were combined with sequences (Sweden: n = 730; other countries: n = 129,913) retrieved from other sources for Nextstrain clade assignment and phylogenetic analyses.ResultsTwelve previously unrecognised SARS-CoV-2 cases were identified: the earliest was sampled on 3 March, 1 week before recognised community transmission. We showed an early influx of clades 20A and 20B from Italy (201/328, 61% of cases exposed abroad) and clades 19A and 20C from Austria (61/328, 19%). Clade 20C dominated the first wave (20C: 908/1,684, 54%; 20B: 438/1,684, 26%; 20A: 263/1,684, 16%), and 800 of 1,684 (48%) Swedish sequences formed a country-specific 20C cluster defined by a spike mutation (G24368T). At the regional level, the proportion of clade 20C sequences correlated with an earlier weighted mean date of COVID-19 deaths.ConclusionCommunity transmission in Sweden started when mitigation efforts still focused on preventing influx. This created a transmission advantage for clade 20C, likely introduced from ongoing cryptic spread in Austria. Therefore, pandemic preparedness should have a comprehensive approach, including capacity for large-scale diagnostics to allow early detection of travel-related cases and community transmission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dyrdak</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodcroft</LastName><ForeName>Emma B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broddesson</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabbe</LastName><ForeName>Malin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franklin</LastName><ForeName>Hildur</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gisslén</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Agency of Sweden, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Maricris E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindh</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nederby-Öhd</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Prevention and Control, Stockholm Region, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ringlander</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundqvist</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, Örebro University, Örebro, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neher</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Biozentrum, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="Y">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">phylogenetics</Keyword><Keyword MajorTopicYN="N">viral respiratory tract infection</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39392000</ArticleId><ArticleId IdType="pmc">PMC11484920</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.41.2400021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, et al. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021;595(7869):707-12. 10.1038/s41586-021-03677-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03677-y</ArticleId><ArticleId IdType="pubmed">34098568</ArticleId></ArticleIdList></Reference><Reference><Citation>Worobey M, Pekar J, Larsen BB, Nelson MI, Hill V, Joy JB, et al. The emergence of SARS-CoV-2 in Europe and North America. Science. 2020;370(6516):564-70. 10.1126/science.abc8169</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8169</ArticleId><ArticleId IdType="pmc">PMC7810038</ArticleId><ArticleId IdType="pubmed">32912998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegnell A, Bessö A, Björkholm B, Byfors S, Carlson J, Tegmark Wisell K. Implementation of a broad public health approach to COVID-19 in Sweden, January 2020 to May 2022. Euro Surveill. 2023;28(41):2300063. 10.2807/1560-7917.ES.2023.28.41.2300063</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.41.2300063</ArticleId><ArticleId IdType="pmc">PMC10571492</ArticleId><ArticleId IdType="pubmed">37824250</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Filipe A, Shepherd JG, Williams T, Hughes J, Aranday-Cortes E, Asamaphan P, et al. Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nat Microbiol. 2021;6(1):112-22. 10.1038/s41564-020-00838-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00838-z</ArticleId><ArticleId IdType="pubmed">33349681</ArticleId></ArticleIdList></Reference><Reference><Citation>Babiker A, Martin MA, Marvil C, Bellman S, Petit Iii RA, Bradley HL, et al. Unrecognized introductions of SARS-CoV-2 into the US state of Georgia shaped the early epidemic. Virus Evol. 2022;8(1):veac011. 10.1093/ve/veac011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac011</ArticleId><ArticleId IdType="pmc">PMC8933693</ArticleId><ArticleId IdType="pubmed">35317348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Greninger AL, Roychoudhury P, Starita LM, Famulare M, Huang M-L, et al. Cryptic transmission of SARS-CoV-2 in Washington state. Science. 2020;370(6516):571-5. 10.1126/science.abc0523</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc0523</ArticleId><ArticleId IdType="pmc">PMC7810035</ArticleId><ArticleId IdType="pubmed">32913002</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges V, Isidro J, Trovão NS, Duarte S, Cortes-Martins H, Martiniano H, et al. SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal. Commun Med (Lond). 2022;2(1):10. 10.1038/s43856-022-00072-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-022-00072-0</ArticleId><ArticleId IdType="pmc">PMC9053228</ArticleId><ArticleId IdType="pubmed">35603268</ArticleId></ArticleIdList></Reference><Reference><Citation>Saguti F, Magnil E, Enache L, Churqui MP, Johansson A, Lumley D, et al. Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19. Water Res. 2021;189:116620. 10.1016/j.watres.2020.116620</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.watres.2020.116620</ArticleId><ArticleId IdType="pmc">PMC7654368</ArticleId><ArticleId IdType="pubmed">33212338</ArticleId></ArticleIdList></Reference><Reference><Citation>La Rosa G, Mancini P, Bonanno Ferraro G, Veneri C, Iaconelli M, Bonadonna L, et al. SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring. Sci Total Environ. 2021;750:141711. 10.1016/j.scitotenv.2020.141711</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.141711</ArticleId><ArticleId IdType="pmc">PMC7428442</ArticleId><ArticleId IdType="pubmed">32835962</ArticleId></ArticleIdList></Reference><Reference><Citation>Fongaro G, Stoco PH, Souza DSM, Grisard EC, Magri ME, Rogovski P, et al. The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019. Sci Total Environ. 2021;778:146198. 10.1016/j.scitotenv.2021.146198</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.146198</ArticleId><ArticleId IdType="pmc">PMC7938741</ArticleId><ArticleId IdType="pubmed">33714813</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JT, Chinazzi M, Perra N, Mu K, Pastore Y Piontti A, Ajelli M, et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature. 2021;600(7887):127-32. 10.1038/s41586-021-04130-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04130-w</ArticleId><ArticleId IdType="pmc">PMC8636257</ArticleId><ArticleId IdType="pubmed">34695837</ArticleId></ArticleIdList></Reference><Reference><Citation>du Plessis L, McCrone JT, Zarebski AE, Hill V, Ruis C, Gutierrez B, et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science. 2021;371(6530):708-12. 10.1126/science.abf2946</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf2946</ArticleId><ArticleId IdType="pmc">PMC7877493</ArticleId><ArticleId IdType="pubmed">33419936</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020;382(24):2302-15. 10.1056/NEJMoa2006100</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006100</ArticleId><ArticleId IdType="pmc">PMC7175425</ArticleId><ArticleId IdType="pubmed">32289214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluhm A, Christandl M, Gesmundo F, Ravn Klausen F, Mančinska L, Steffan V, et al. SARS-CoV-2 transmission routes from genetic data: A Danish case study. PLoS One. 2020;15(10):e0241405. 10.1371/journal.pone.0241405</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241405</ArticleId><ArticleId IdType="pmc">PMC7595399</ArticleId><ArticleId IdType="pubmed">33119657</ArticleId></ArticleIdList></Reference><Reference><Citation>Muenchhoff M, Graf A, Krebs S, Quartucci C, Hasmann S, Hellmuth JC, et al. Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. Euro Surveill. 2021;26(43):2002066. 10.2807/1560-7917.ES.2021.26.43.2002066</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.43.2002066</ArticleId><ArticleId IdType="pmc">PMC8555370</ArticleId><ArticleId IdType="pubmed">34713795</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksamentov I, Roemer C, Hodcroft EB, Neher RA. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6(67):3773. 10.21105/joss.03773</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03773</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):30494. 10.2807/1560-7917.ES.2017.22.13.30494</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.13.30494</ArticleId><ArticleId IdType="pmc">PMC5388101</ArticleId><ArticleId IdType="pubmed">28382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddleston J, Hadfield J, Sibley TR, Lee J, Fay K, Ilcisin M, et al. Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens. J Open Source Softw. 2021;6(57):2906. 10.21105/joss.02906</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.02906</ArticleId><ArticleId IdType="pmc">PMC8237802</ArticleId><ArticleId IdType="pubmed">34189396</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio N, Kalaghatgi P, Turakhia Y, Corbett-Detig R, Minh BQ, Goldman N. Maximum likelihood pandemic-scale phylogenetics. Nat Genet. 2023;55(5):746-52. 10.1038/s41588-023-01368-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-023-01368-0</ArticleId><ArticleId IdType="pmc">PMC10181937</ArticleId><ArticleId IdType="pubmed">37038003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagulenko P, Puller V, Neher RA. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol. 2018;4(1):vex042. 10.1093/ve/vex042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vex042</ArticleId><ArticleId IdType="pmc">PMC5758920</ArticleId><ArticleId IdType="pubmed">29340210</ArticleId></ArticleIdList></Reference><Reference><Citation>McBroome J, Thornlow B, Hinrichs AS, Kramer A, De Maio N, Goldman N, et al. A daily-updated database and tools for comprehensive SARS-CoV-2 mutation-annotated trees. Mol Biol Evol. 2021;38(12):5819-24. 10.1093/molbev/msab264</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab264</ArticleId><ArticleId IdType="pmc">PMC8662617</ArticleId><ArticleId IdType="pubmed">34469548</ArticleId></ArticleIdList></Reference><Reference><Citation>The Public Health Agency of Sweden (PHAS). Bekräftade fall av covid-19 i Sverige. [Confirmed cases of covid-19 in Sweden]. Solna: PHAS; 2 Feb 2024. Swedish. Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuella-utbrott/covid-19/statistik-och-analyser/bekraftade-fall-i-sverige/</Citation></Reference><Reference><Citation>Díez-Fuertes F, Iglesias-Caballero M, García-Pérez J, Monzón S, Jiménez P, Varona S, et al. A founder effect led early SARS-CoV-2 transmission in Spain. J Virol. 2021;95(3):e01583-20. 10.1128/JVI.01583-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01583-20</ArticleId><ArticleId IdType="pmc">PMC7925114</ArticleId><ArticleId IdType="pubmed">33127745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui JL, McCrone JT, Lambert B, Bajaj S, Inward RPD, Bosetti P, et al. Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1. Science. 2023;381(6655):336-43. 10.1126/science.adg6605</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg6605</ArticleId><ArticleId IdType="pmc">PMC10866301</ArticleId><ArticleId IdType="pubmed">37471538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemieux JE, Siddle KJ, Shaw BM, Loreth C, Schaffner SF, Gladden-Young A, et al. Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. Science. 2021;371(6529):eabe3261. 10.1126/science.abe3261</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe3261</ArticleId><ArticleId IdType="pmc">PMC7857412</ArticleId><ArticleId IdType="pubmed">33303686</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong Nguyen P, Kant R, Van den Broeck F, Suvanto MT, Alburkat H, Virtanen J, et al. The phylodynamics of SARS-CoV-2 during 2020 in Finland. Commun Med (Lond). 2022;2(1):65. 10.1038/s43856-022-00130-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-022-00130-7</ArticleId><ArticleId IdType="pmc">PMC9187640</ArticleId><ArticleId IdType="pubmed">35698660</ArticleId></ArticleIdList></Reference><Reference><Citation>Murall CL, Fournier E, Galvez JH, N’Guessan A, Reiling SJ, Quirion PO, et al. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada. Genome Med. 2021;13(1):169. 10.1186/s13073-021-00986-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00986-9</ArticleId><ArticleId IdType="pmc">PMC8550813</ArticleId><ArticleId IdType="pubmed">34706766</ArticleId></ArticleIdList></Reference><Reference><Citation>Popa A, Genger JW, Nicholson MD, Penz T, Schmid D, Aberle SW, et al. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med. 2020;12(573):eabe2555. 10.1126/scitranslmed.abe2555</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe2555</ArticleId><ArticleId IdType="pmc">PMC7857414</ArticleId><ArticleId IdType="pubmed">33229462</ArticleId></ArticleIdList></Reference><Reference><Citation>Stange M, Mari A, Roloff T, Seth-Smith HM, Schweitzer M, Brunner M, et al. SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathog. 2021;17(3):e1009374. 10.1371/journal.ppat.1009374</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009374</ArticleId><ArticleId IdType="pmc">PMC8011817</ArticleId><ArticleId IdType="pubmed">33740028</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-Martínez CL, Kampmeier S, Kümpers P, Schwierzeck V, Hennies M, Hafezi W, et al. A pandemic in times of global tourism: Superspreading and exportation of COVID-19 cases from a ski area in Austria. J Clin Microbiol. 2020;58(6):e00588-20. 10.1128/JCM.00588-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00588-20</ArticleId><ArticleId IdType="pmc">PMC7269389</ArticleId><ArticleId IdType="pubmed">32245833</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020;182(5):1284-1294.e9. 10.1016/j.cell.2020.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.012</ArticleId><ArticleId IdType="pmc">PMC7366990</ArticleId><ArticleId IdType="pubmed">32730807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J, Hickman RA, Li J, Lu X, Lindahl JF, Lundkvist Å, et al. Spatio-temporal mutational profile appearances of Swedish SARS-CoV-2 during the early pandemic. Viruses. 2020;12(9):1026. 10.3390/v12091026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12091026</ArticleId><ArticleId IdType="pmc">PMC7551444</ArticleId><ArticleId IdType="pubmed">32937868</ArticleId></ArticleIdList></Reference><Reference><Citation>The Public Health Agency of Sweden (PHAS). Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare. [Detection of antibodies to SARS-CoV-2 in blood donors]. Solna: PHAS; 28 Oct 2021. Swedish. Available from: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/p/pavisning-av-antikroppar-efter-genomgangen-covid-19-hos-blodgivare-delrapport-2/#:~:text=Unders%C3%B6kningar%20p%C3%A5g%C3%A5r%20f%C3%B6r%20p%C3%A5visning%20av,p%C3%A5g%C3%A5ende%20pandemi%202020%20och%202021</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>